Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Parkinson's Disease
100%
Deep Brain Stimulation
20%
Patients with Parkinson's Disease
19%
Multiple System Atrophy
18%
Movement Disorders
16%
Disease-modifying Therapy
13%
Meta-analysis
12%
Hospitalized Patients
12%
Parkinson Patients
11%
Motor Fluctuations
8%
Racial Groups
8%
Ethnic Groups
8%
Dyskinesia
7%
PDQ-39
7%
Case Series Report
7%
Risk Factors
7%
Hispanic
7%
Dystonia
7%
Clinical Outcomes
7%
Unified Parkinson's Disease Rating Scale (UPDRS)
6%
Clinical Features
6%
Clinical Phenotype
6%
Globus Pallidus Internus
6%
Vertical Supranuclear Gaze Palsy
6%
Non-motor Symptoms
6%
Progressive Supranuclear Palsy
6%
Temporal Trends
6%
Novel Therapies
6%
Economic Outcomes
6%
MPPD Model
6%
Ethnoracial Differences
6%
Periodic Limb Movements
6%
Dysphagia
6%
Cannabis Oil
6%
Wearing-off
6%
Caudal Zona Incerta
6%
Ventral Intermediate nucleus
6%
Epidemiology
6%
Arm Swing
6%
Neuromodulation Therapy
6%
Center of Excellence
6%
Neuroprotection
6%
Ethnic Background
6%
22q11.2 Microdeletion
6%
Multiple Sclerosis
6%
Oculomotor Tests
6%
Prodromal Markers
6%
Hospital Readmission
6%
Post-traumatic Epilepsy
6%
Traumatic Brain Injury
6%
Medicine and Dentistry
Parkinson's Disease
61%
Meta-Analysis
18%
Parkinsonism
17%
Stereotypic Movement Disorder
16%
Deep Brain Stimulation
13%
Systematic Review
12%
Diseases
12%
Globus pallidus
9%
Progressive Supranuclear Palsy
9%
Clinical Feature
9%
Education
8%
Disease Modifying Therapy
8%
Clinical Trial
8%
Dyskinesia
6%
Gaze Paralysis
6%
Shy-Drager Syndrome
6%
Tau
6%
Nephrology
6%
Orofacial Dyskinesia
6%
Plummer-Vinson Syndrome
6%
Neglected Tropical Diseases
6%
Symptomatic Treatment
6%
Zona Incerta
6%
Essential Tremor
6%
Anti N Methyl D Aspartate Receptor Encephalitis
6%
Spasmodic dysphonia
6%
Periodontal Disease
6%
Hansen's disease
6%
Neuropsychiatric Symptom
6%
Osteopenia
6%
Parkinson's Disease Clinical Trial
6%
Multiple Sclerosis
6%
Body Fat Mass
6%
Arm
6%
Gait
6%
Levodopa
6%
Anatomical Concepts
6%
Glycolysis
6%
Cognition
6%
Osteoporosis
6%
Scoping Review
6%
Prevalence
5%
Phosphoglycerate Kinase
5%
Randomized Clinical Trials
5%
Speech Production
5%
